Final Conclusions

Prabodh Malhotra

Chapter 11 in Impact of TRIPS in India, 2010, pp 214-224 from Palgrave Macmillan

Abstract: Abstract Based on the discussion in the previous chapters, the main conclusions of this book are brought together in this chapter. As has been stated, the book deals with the impact of the TRIPS agreement on the pharmaceutical industry and the access to medicines in India, acknowledging that the introduction of the TRIPS compliant regime from 1 January 2005 marked a major shift in India’s public policy on the protection of intellectual property rights (IPRs) and will have important repercussions for several industries and sectors. However, the focus of this book is only on the pharmaceutical industry and healthcare in India.

Keywords: Foreign Direct Investment; Public Expenditure; Innovative Activity; Drug Price; Price Control (search for similar items in EconPapers)
Date: 2010
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pal:palchp:978-0-230-29074-7_11

Ordering information: This item can be ordered from
http://www.palgrave.com/9780230290747

DOI: 10.1057/9780230290747_11

Access Statistics for this chapter

More chapters in Palgrave Macmillan Books from Palgrave Macmillan
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().